Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Successful Vaccination Against Anthrax Supports Cobra's Oral Vaccine Delivery Technology
April 29th, 2009
Cobra Biomanufacturing Plc (AIM: CBF), the international manufacturer of biopharmaceuticals, announces the results of a research collaboration with the UK Ministry of Defence agency Dstl (Defence Science and Technology Laboratory), Porton Down, UK, on the use of Cobra's oral vaccination platform that allows easy oral administration and cost effective manufacture of a vaccine against anthrax. The experiments conducted at Dstl and funded by Ploughshare Innovations Ltd, demonstrated that the Salmonella-based oral ORT-VAC vaccines containing stable plasmids expressing a vaccine antigen offered significantly greater protection in mice against a lethal...
Source: Vaccine Weekly (2009-04-29)
|
